Randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence [ 2016 - ]

Research Grant

Researchers: A/Pr Nadine Ezard (Principal investigator) ,  Prof Nicholas Lintzeris (Principal investigator) ,  A/Pr Raimondo Bruno ,  A/Pr Rebecca McKetin ,  A/Pr Robert Ali
View all 9 related researchers

Brief description Addiction to methamphetamines (‘ice’) is a growing community problem linked to serious disease and death. Current counselling approaches have limited success on their own, and more effective treatments linked to medications are needed. Lisdexamfetamine is a newly licenced stimulant medication with great promise in treating these patients. This trial will examine whether lisdexamfetamine (with counselling) safely reduces methamphetamine use and improves health and wellbeing among heavy users.

Funding Amount $1,303,735.00

Funding Scheme Project Grants

Notes Standard Project Grant